We first compared the expression levels of CDC37 between prostate cancer cell lines DU-145 and LNCaP, a castration-resistant prostate cancer (CRPC, also known as neuroendocrine prostate cancer (NEPC) cell line PC-3), and a normal prostate cell line (RWPE-1). The gene discussed is CDC37; the disease is prostate cancer.